165 related articles for article (PubMed ID: 30688733)
1. Multiple Myeloma of Testes and Spermatic Cord on 18F-FDG PET/CT.
Velaga J; Liang HH; Gopalakrishnan SK
Clin Nucl Med; 2019 Apr; 44(4):297-298. PubMed ID: 30688733
[TBL] [Abstract][Full Text] [Related]
2. Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple Myeloma.
Causa Andrieu PI; Das JP; Woo S; Ryan R; Akin O; Ulaner GA
Clin Nucl Med; 2020 Nov; 45(11):873-875. PubMed ID: 32657873
[TBL] [Abstract][Full Text] [Related]
3. Rare Extramedullary Cardiac Involvement of Recurrent Multiple Myeloma Suspected on 18F-FDG and Confirmed on 18F-Fluorocholine.
Zhang-Yin J; Garderet L; Martino S; Montravers F; Talbot JN
Clin Nucl Med; 2020 Nov; 45(11):916-918. PubMed ID: 32796239
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
[TBL] [Abstract][Full Text] [Related]
5. Skeletal Superscan on 18F-FDG PET/CT in a Patient With Multiple Myeloma.
Fu Z; Chen X; Yang X; Li Q
Clin Nucl Med; 2019 Feb; 44(2):169-170. PubMed ID: 30516669
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of [
Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Baseline
Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
[TBL] [Abstract][Full Text] [Related]
8. FDG PET-CT in Adrenal Multiple Myeloma.
Choudhury S; Purandare N; Agrawal A; Shah S; Rangarajan V
Clin Nucl Med; 2018 Sep; 43(9):691-692. PubMed ID: 30015660
[TBL] [Abstract][Full Text] [Related]
9. Muscle Involvement of Multiple Myeloma Revealed by FDG PET/CT.
Liang M; Su M; Wang R; Wang W; Fan C
Clin Nucl Med; 2017 Apr; 42(4):300-302. PubMed ID: 28195903
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
11. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
[TBL] [Abstract][Full Text] [Related]
12. Diffuse Infiltration of Multiple Myeloma With Initial Manifestation of Cavernous Sinus Syndrome Unveiled by 18F-FDG PET/CT.
Li C; Shao F; Yang Y; Lan X
Clin Nucl Med; 2019 Sep; 44(9):746-747. PubMed ID: 31306198
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT in Isolated Spermatic Cord Metastasis From Colon Cancer.
Ji X; Dong A
Clin Nucl Med; 2022 Jan; 47(1):e81-e82. PubMed ID: 34874356
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
[TBL] [Abstract][Full Text] [Related]
15. Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.
Tirumani SH; Sakellis C; Jacene H; Shinagare AB; Munshi NC; Ramaiya NH; Van den Abbeele AD
Clin Nucl Med; 2016 Jan; 41(1):e7-13. PubMed ID: 26252323
[TBL] [Abstract][Full Text] [Related]
16. Whole-body (18)F-FDG PET identifies high-risk myeloma.
Durie BG; Waxman AD; D'Agnolo A; Williams CM
J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
[TBL] [Abstract][Full Text] [Related]
17. [18F-FDG PET/CT features on paraganglioma of testis with multiple lymph node and lung metastasis: A case report and literature review].
Lü X; Wang Y; Xu P; Dong C; Xiao Z; Jiang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1164-1168. PubMed ID: 30523240
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.
Nanni C; Zamagni E
PET Clin; 2019 Jul; 14(3):383-389. PubMed ID: 31084777
[TBL] [Abstract][Full Text] [Related]
19. A Rare Extramedullary Involvement Site in Patients With Multiple Myeloma: Stomach.
Gülbahar Ateş S; Uçmak G
Clin Nucl Med; 2022 Nov; 47(11):e702-e703. PubMed ID: 35619203
[TBL] [Abstract][Full Text] [Related]
20. Role of
Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
